Investor Connect - 791 - Ronan O'Hagan of Bectas Therapeutics Inc. episode artwork

EPISODE · Jan 26, 2024 · 23 MIN

Investor Connect - 791 - Ronan O'Hagan of Bectas Therapeutics Inc.

from Investor Connect Podcast

On this episode of Investor Connect, Hall T. Martin welcomes Ronan O'Hagan, President & CEO of Bectas Therapeutics Inc., a groundbreaking biotech company focused on revolutionizing precision oncology. Based in [City, State/Country], Bectas Therapeutics is committed to developing cancer therapies that target over 400,000 patients annually who do not benefit from the existing standard-of-care treatments. Ronan O'Hagan boasts over two decades of experience in building biotech teams and businesses, contributing to the development of more than 20 Investigational New Drugs (INDs) and four approved drugs. As the President & CEO of Bectas Therapeutics, O'Hagan leads a team with a mission to provide personalized cancer therapies, increasing the probability of success by fivefold and significantly reducing both cost and time in clinical development. The Bectas advisory board includes luminaries such as Dr. James Allison, a Nobel Laureate for his work in immune oncology, and Dr. Keith Flaherty, a serial entrepreneur in precision oncology. Bectas Therapeutics Inc. focuses on developing cancer therapies tailored for patients who do not benefit from existing standard treatments, a population exceeding 400,000 individuals annually. Their precision approach ensures each patient receives the right drug for their specific cancer, significantly improving the chances of success and reducing costs and time in clinical development. Ronan discusses the company's precision cancer therapies, leveraging human patient data. Bectas aims to bring Best-In-Class therapies with a unique blood-based biomarker, promising rapid value creation and potential early exits for investors. O'Hagan emphasizes the significance of clinical proof of concept and highlights the company's mission-driven approach to cancer health equity. Connect with Ronan O'Hagan and Bectas Therapeutics: LinkedIn: Ronan O'Hagan; Twitter: @ohaganr _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact [email protected] Please follow, share, and leave a review. Music courtesy of Bensound.

Episode metadata supplied by the publisher feed · Published Jan 26, 2024

Embed this episode

NOW PLAYING

Investor Connect - 791 - Ronan O'Hagan of Bectas Therapeutics Inc.

0:00 23:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Investor Connect Podcast?

This episode is 23 minutes long.

When was this Investor Connect Podcast episode published?

This episode was published on January 26, 2024.

Can I download this Investor Connect Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!